Rigel Pharmaceuticals Inc (RIGL) — Capital Reinvestment Ratio
Rigel Pharmaceuticals Inc (RIGL) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($21.98 Million) in capital expenditures ($12.00K). Check RIGL tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Rigel Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2024)
This chart tracks Rigel Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Rigel Pharmaceuticals Inc.
Annual Capital Reinvestment Ratio for Rigel Pharmaceuticals Inc (2010–2024)
Year-by-year Capital Reinvestment Ratio for Rigel Pharmaceuticals Inc from 2010 to 2024. See RIGL FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $31.47 Million | $396.00K | ▼ -88.2% |
| 2021 | 0.11x | $5.88 Million | $627.00K | ▲ +40.1% |
| 2010 | 0.08x | $46.74 Million | $3.56 Million | — |